Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

CCCA Assessed by Ki67 Drop Below <2.7% From Baseline × capivasertib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Neoplasm Metastasis 1 Moderate Hepatic Impairment 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia 1 Healthy Participants 1 Exanthema 1 Disease Progression 1 Diarrhea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡